Use of the peptide AsnAsp-Asp-Cys-GluLeuCysVal-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu alone or in combination with the peptide Thr-Thr-Ser-Gin-ValArg-Pro-Arg as a therapeutic agent

Details for Australian Patent Application No. 2008303948 (hide)

International Classifications

Event Publications

15 April 2010 PCT application entered the National Phase

PCT publication WO2009/039986 Priority application(s): WO2009/039986

22 April 2010 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name mondoBIOTECH Laboratories AG, Application No. 2008303948, under INID (54) correct the title to read Use of the peptide AsnAsp-Asp-Cys-GluLeu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu alone or in combination with the peptide Thr-Thr-Ser-Gln-ValArgPro-Arg as a therapeutic agent

20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.